Press "Enter" to skip to content

Glenmark gets USFDA nod for pneumonia treatment drug

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Atovaquone Oral Suspension USP in the strength of 750 mg/5 mL," the company said in a BSE filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-pneumonia-treatment-drug/66749247?utm_source=RSS&utm_medium=ETRSS

Also Read:   Roche names new head of $13 billion diagnostics unit